Trial site
Liverpool University Hospitals NHS Foundation Trust
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- ANCA-associated vasculitis2 trials
- Gastric and oesophageal cancer2 trials
- Alzheimer disease1 trial
- Colorectal cancer1 trial
- Down syndrome1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- Idiopathic pulmonary fibrosis1 trial
- Liver and biliary tract cancer1 trial
- Macular degeneration1 trial
- Pancreatic cancer1 trial
- Peripheral artery disease1 trial
- and 1 more
- Phase
- Phase 23 trials
- Phase 33 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed2 trials
- Not yet recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Imperial College London3 trials
- University of Liverpool2 trials
- AC Immune SA1 trial
- Aptarion Biotech AG1 trial
- Cardiovascular and Interventional Radiological Society of Europe1 trial
- and 6 more
Running trials
Recruiting
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study
Active, not recruiting
Recruiting
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Active, not recruiting
Multivariate Biomarker Study for Sarcopenia in Heart Failure
Recruiting
Recruiting
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Alzheimer disease1 recruiting
- Colorectal cancer1 recruiting
- Down syndrome1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Completed
Terminated
A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026